Frederiksberg Hospital is a medium-sized government-owned general hospital located in Frederiksberg, Denmark. It has 380 beds and an emergency department. The hospital is a teaching hospital for medical students from Copenhagen University.

During the past decade, Cardiology department Y, Bispebjerg-Frederiksberg Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cardiology department Y, Bispebjerg-Frederiksberg Hospital" #1 collaborator was "Rigshospitalet, Denmark" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Cardiology department Y, Bispebjerg-Frederiksberg Hospital" are "Atrial Fibrillation" (2 trials) and "Left Ventricular Diastolic Dysfunction" (1 trials). Many other conditions were trialed in "Cardiology department Y, Bispebjerg-Frederiksberg Hospital" in a lesser frequency.

The vast majority of trials in "Cardiology department Y, Bispebjerg-Frederiksberg Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Cardiology department Y, Bispebjerg-Frederiksberg Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Cardiology department Y, Bispebjerg-Frederiksberg Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cardiology department Y, Bispebjerg-Frederiksberg Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".